1421 related articles for article (PubMed ID: 9165690)
1. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
2. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
4. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
5. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
6. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
Robinson M
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
[TBL] [Abstract][Full Text] [Related]
7. Acid suppression therapy: where do we go from here?
Scarpignato C; Pelosini I; Di Mario F
Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
[TBL] [Abstract][Full Text] [Related]
8. Long-term management of gastroesophageal reflux disease and its complications.
Richter JE
Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
[TBL] [Abstract][Full Text] [Related]
9. Intermittent treatment of duodenal ulcer for long term medical management.
Bardhan KD
Postgrad Med J; 1988; 64 Suppl 1():40-6. PubMed ID: 2901744
[TBL] [Abstract][Full Text] [Related]
10. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Chassany O; Bergmann JF
Rev Prat; 1998 Apr; 48(8):893-8. PubMed ID: 11767336
[No Abstract] [Full Text] [Related]
11. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
Katz PO; Tutuian R
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
Lazzaroni M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
[TBL] [Abstract][Full Text] [Related]
13. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
Dajani EZ
J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
[TBL] [Abstract][Full Text] [Related]
14. Management strategies for gastroesophageal reflux disease.
Bak YT
J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
Gisbert JP; Pajares JM; Losa C
Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
[TBL] [Abstract][Full Text] [Related]
16. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
17. Medical therapy of extraesophageal gastroesophageal reflux disease.
Katz PO
J Clin Gastroenterol; 2000 Apr; 30(3 Suppl):S42-4. PubMed ID: 10777172
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches to healing esophagitis.
Boyce HW
Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
[TBL] [Abstract][Full Text] [Related]
20. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
Bursey F; Crowley M; Janes C; Turner CJ
CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]